FDA and Depakote Birth Injury Resources Warn of Increased Risk of Birth Defects in Babies Exposed to Valproate Sodium During Pregnancy
Links shared publicly online about this topic.
- 678total visits
FDA and Depakote Birth Injury Resources Warn of Increased Risk of Birth Defects in Babies Exposed to Valproate Sodium During Pregnancy
The US Food and Drug Administration has issued a warning to health care professionals and patients about the potential increased risk of birth injuries and birth defects when valproate sodium and related products (e.g. Depacon, Depakote or Stavzor) are used by mothers during pregnancy. Depakote Birth Injury Resources (DepakoteBirthInjury.com) offers information and resources about the possible side effects of valproate sodium, including neural tube malformations, craniofacial defects and cardiov
View full resource at prweb.com
Tags: Migraine Prevention Medication, Seizure Medication, Mineral, Sodium, Children's Health, Childbirth, FDA, Epilepsy Medication
Most Recently Shared on December 5, 2010 at 1:54 am By:
Depakote and birth injuries according to FDA report http://bit.ly/fndQ95
Advertisement
